Premium Acquisition SPRINT™

Turn a strong business into the buyer’s clear first choice

Schedule a Strategic Fit Call

The Premium Acquisition Sprint is a focused, 90-day engagement designed to elevate how buyers see, compare, and value your business.

This sprint helps leadership teams translate strong performance into a premium investor narrative: one that clearly communicates differentiation, proves category leadership, and creates confidence before formal processes begin.

Valuation isn’t just about numbers. It’s about buyer conviction, and conviction is built through clarity, proof, and competitive tension.

Dashboard mockup

Who this is for

The Premium Acquisition Sprint is designed for healthtech and pharmacy leaders who recognize one or more of these signals:
You have a strong business, but buyers aren’t fully seeing the differentiation
The numbers are solid, yet the story doesn’t command a premium
Proof exists, but it’s scattered and not packaged for diligence
Buyer conversations feel transactional instead of competitive
You don’t need a new strategy. You need a premium investor narrative, backed by proof, that buyers can’t ignore.

Why this matters more than most teams realize

Strong revenue and EBITDA do not automatically translate into strong evaluation.
Buyers pay premiums when they can clearly see:
Why your business leads the category
How your differentiation sustains growth
Where upside exists and why it’s defensible
Why choosing you is the lower-risk decision
When that story isn’t clearly framed and supported, buyers discount value, even when performance is strong.

The Premium Acquisition Sprint ensures buyers aren’t left to interpret your value.You show it to them clearly and credibly.
Schedule a Strategic Fit Call

What changes in 90 days

By the end of the Premium Acquisition Sprint, you’ll have a buyer-ready narrative that positions your company as the obvious premium choice.

You’ll leave with:
01

Premium acquisition narrative

A clear, investor-ready story that positions your business as a category leader
02

Buyer-ready proof set

Packaged traction, outcomes, and KPIs designed to support valuation and accelerate diligence
03

Target buyer strategy

Clear prioritization of acquirers and partners to create meaningful competitive tension
04

Leadership alignment

One valuation-focused story your executive team can confidently carry into every conversation
05

Pre-process confidence

Stronger buyer conviction before formal processes begin

HOW THE SPRINT WORKS

Built for investor and diligence scrutiny

The Premium Acquisition Sprint follows a structured, four-phase process designed around how buyers actually evaluate risk, value, and upside.

Phase 1:

Assessment & Alignment

Identify valuation risk, narrative gaps, and misalignment before buyers do

Phase 2:

Position for Premium

Craft a clear investor narrative that proves differentiation and category leadership

Phase 3:

Prove Market Value

Package traction, outcomes, and KPIs into a cohesive, buyer-ready proof set

Phase 4:

Create Competitive Tension

Map priority acquirers, sharpen executive visibility, and sustain buyer momentum

Why this works

Strong companies lose leverage when buyers control the narrative.

The Premium Acquisition Sprint works because it’s:
Designed through a buyer lens.
Built around how acquirers compare options and make decisions.
Proof-driven, not promise-driven.
Grounds the narrative in real outcomes, traction, and defensible upside.
Positioned for comparison.
Helps buyers see why your business stands above alternatives.
Focused on value, not price.
Shifts conversations away from discounting and toward premium outcomes.

How this fits with the other
Legacy DNA paths

Different stages require different leverage.
“We need
clarity before
pressure hits.”
“Buyers aren’t
seeing our
full value.”
“We need
predictable,
scalable
enterprise value.”
Not sure where you fit? Start with the Exit Readiness Scorecard →

Why Legacy DNA?

We specialize in commercialization as a valuation lever,
not a marketing exercise.

Our work is grounded in doctoral-level rigor and real-world execution, shaped by Dr. Roxie Mooney’s research and experience commercializing healthcare and technology innovation. That foundation informs how Legacy DNA approaches clarity, risk reduction, and value creation, and how our team delivers work that holds up under buyer scrutiny.

Every engagement is senior-led and standards-driven, designed to perform where it matters most: boardrooms, IC meetings, and diligence conversations. We combine deep healthcare commercialization expertise with a clear understanding of buyer psychology, regulatory complexity, and enterprise value creation.

We’ve helped leadership teams reposition strong companies into premium acquisition targets, supporting multiple successful exits by shaping how buyers see, value, and compete for what’s been built.

Your Next Step

Schedule Your
Strategic Fit Call

It’s a practical conversation to determine whether the Premium Acquisition Sprint fits your situation and what will most effectively strengthen your valuation story.

No pitch. No pressure. Just clarity.

Book my Strategic Fit Call